Ngā hua rapu - Ting‐Chao Chou

Whakamahine hua
  1. 1
    A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems.

    A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems. mā Ting‐Chao Chou, Paul Talalay

    I whakaputaina 1977
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity.

    Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity. mā Ting‐Chao Chou, Ailing Chang, S Shu

    I whakaputaina 1988
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy.

    Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy. mā S Shu, Ting‐Chao Chou, Steven A. Rosenberg

    I whakaputaina 1987
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    SYNERGISTIC INTERACTIONS OF CYCLOSPORINE AND RAPAMYCIN TO INHIBIT IMMUNE PERFORMANCES OF NORMAL HUMAN PERIPHERAL BLOOD LYMPHOCYTES IN VITRO

    SYNERGISTIC INTERACTIONS OF CYCLOSPORINE AND RAPAMYCIN TO INHIBIT IMMUNE PERFORMANCES OF NORMAL HUMAN PERIPHERAL BLOOD LYMPHOCYTES IN VITRO mā Barry D. Kahan, SHEENA GIBBONS, Neelam Tejpal, M. STANISLAW, STEPKOWSKI, Ting‐Chao Chou

    I whakaputaina 1991
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Strong in Vitro Synergy Between the Fusion Inhibitor T-20 and the CXCR4 Blocker AMD-3100

    Strong in Vitro Synergy Between the Fusion Inhibitor T-20 and the CXCR4 Blocker AMD-3100 mā C cile L. Tremblay, Christopher S. Kollmann, Fran oise Giguel, Ting‐Chao Chou, Martin Hirsch

    I whakaputaina 2000
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Quantitation of chemopreventive synergism between (-)-epigallocatechin- 3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells

    Quantitation of chemopreventive synergism between (-)-epigallocatechin- 3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells mā Avi Khafif, Stimson P. Schantz, Ting‐Chao Chou, David R. Edelstein, Peter G. Sacks

    I whakaputaina 1998
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer

    A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer mā Shu‐Fu Lin, Jen‐Der Lin, Chuen Hsueh, Ting‐Chao Chou, Richard J. Wong

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Targeting Ataxia Telangiectasia-Mutated and Rad3-Related for Anaplastic Thyroid Cancer

    Targeting Ataxia Telangiectasia-Mutated and Rad3-Related for Anaplastic Thyroid Cancer mā Shu‐Fu Lin, Chuen Hsueh, Wei‐Yi Chen, Ting‐Chao Chou, Richard J. Wong

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidine

    Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidine mā Victoria A. Johnson, Bruce D. Walker, Maeve Barlow, Timothy Paradis, Ting‐Chao Chou, Martin Hirsch

    I whakaputaina 1989
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Synergistic Anticancer Effects of Ganciclovir/Thymidine Kinase and 5-Fluorocytosine/Cytosine Deaminase Gene Therapies

    Synergistic Anticancer Effects of Ganciclovir/Thymidine Kinase and 5-Fluorocytosine/Cytosine Deaminase Gene Therapies mā Manish K. Aghi, C M Kramm, Ting‐Chao Chou, X. O. Breakefield, E. Antonio Chiocca

    I whakaputaina 1998
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    EFFECTS OF THE PHARMACOKINETIC INTERACTION BETWEEN ORALLY ADMINISTERED SIROLIMUS AND CYCLOSPORINE ON THE SYNERGISTIC PROLONGATION OF HEART ALLOGRAFT SURVIVAL IN RATS1

    EFFECTS OF THE PHARMACOKINETIC INTERACTION BETWEEN ORALLY ADMINISTERED SIROLIMUS AND CYCLOSPORINE ON THE SYNERGISTIC PROLONGATION OF HEART ALLOGRAFT SURVIVAL IN RATS1 mā Stanislaw M. Stepkowski, Kimberly L. Napoli, Mouer Wang, Xiumei Qu, Ting‐Chao Chou, Barry D. Kahan

    I whakaputaina 1996
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon

    Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon mā Kevan L. Hartshorn, Markus Vogt, Ting‐Chao Chou, Richard S. Blumberg, Roy Byington, Robert T. Schooley, Martin Hirsch

    I whakaputaina 1987
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Anti-Human Immunodeficiency Virus Interactions of SCH-C (SCH 351125), a CCR5 Antagonist, with Other Antiretroviral Agents In Vitro

    Anti-Human Immunodeficiency Virus Interactions of SCH-C (SCH 351125), a CCR5 Antagonist, with Other Antiretroviral Agents In Vitro mā Cécile Tremblay, Françoise Giguel, Christopher S. Kollmann, Yongbiao Guan, Ting‐Chao Chou, Bahige M. Baroudy, Martin Hirsch

    I whakaputaina 2002
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection

    Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection mā Stanislaw M. Stepkowski, Lei Tian, Kimberly L. Napoli, Rafik Ghobrial, M.E Wang, Ting‐Chao Chou, B D Kahan

    I whakaputaina 1997
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Pharmacokinetic Interactions Augment Toxicities of Sirolimus/Cyclosporine Combinations

    Pharmacokinetic Interactions Augment Toxicities of Sirolimus/Cyclosporine Combinations mā Hemangshu Podder, Stanislaw M. Stepkowski, Kimberly L. Napoli, James H. Clark, Regina Verani, Ting‐Chao Chou, Barry D. Kahan

    I whakaputaina 2001
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine

    BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine mā D. D. Richman, A. S. Rosenthal, M. T. SKOOG, Robert J. Eckner, Ting‐Chao Chou, John P. Sabo, V J Merluzzi

    I whakaputaina 1991
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Desoxyepothilone B: An efficacious microtubule-targeted antitumor agent with a promising <i>in vivo</i> profile relative to epothilone B

    Desoxyepothilone B: An efficacious microtubule-targeted antitumor agent with a promising <i>in vivo</i> profile relative to epothilone B mā Ting‐Chao Chou, Xiu-Guo Zhang, Aaron Balog, Dai‐Shi Su, Dong‐Fang Meng, Kenneth A. Savin, Joseph R. Bertino, Samuel J. Danishefsky

    I whakaputaina 1998
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: Curative effects of desoxyepothilones B and F against human tumor xenografts in nude mice

    The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: Curative effects of desoxyepothilones B and F against human tumor xenogra... mā Ting‐Chao Chou, Owen A. O’Connor, William P. Tong, Yongbiao Guan, Zui-Guo Zhang, Shawn J. Stachel, Chulbom Lee, Samuel J. Danishefsky

    I whakaputaina 2001
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel

    Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel mā Ting‐Chao Chou, Xiu-Guo Zhang, Christina R. Harris, Scott D. Kuduk, Aaron Balog, Kenneth A. Savin, Joseph R. Bertino, Samuel J. Danishefsky

    I whakaputaina 1998
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer

    Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer mā Shu‐Fu Lin, Sizhi Paul Gao, Daniel L. Price, Sen Li, Ting‐Chao Chou, Paramjeet Singh, Yu‐Yao Huang, Yuman Fong, Richard J. Wong

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: